249 related articles for article (PubMed ID: 14651620)
1. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance.
Dover LG; Corsino PE; Daniels IR; Cocklin SL; Tatituri V; Besra GS; Fütterer K
J Mol Biol; 2004 Jul; 340(5):1095-105. PubMed ID: 15236969
[TBL] [Abstract][Full Text] [Related]
3. Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide.
Zhang HN; Xu ZW; Jiang HW; Wu FL; He X; Liu Y; Guo SJ; Li Y; Bi LJ; Deng JY; Zhang XE; Tao SC
Sci Rep; 2017 Jul; 7(1):5860. PubMed ID: 28725053
[TBL] [Abstract][Full Text] [Related]
4. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
5. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
[TBL] [Abstract][Full Text] [Related]
6. The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation.
Leiba J; Carrère-Kremer S; Blondiaux N; Dimala MM; Wohlkönig A; Baulard A; Kremer L; Molle V
Biochem Biophys Res Commun; 2014 Apr; 446(4):1132-8. PubMed ID: 24667600
[TBL] [Abstract][Full Text] [Related]
7. Activation of the pro-drug ethionamide is regulated in mycobacteria.
Baulard AR; Betts JC; Engohang-Ndong J; Quan S; McAdam RA; Brennan PJ; Locht C; Besra GS
J Biol Chem; 2000 Sep; 275(36):28326-31. PubMed ID: 10869356
[TBL] [Abstract][Full Text] [Related]
8. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates.
da Silva DA; Ferreira NV; Rego AM; Barbosa PCP; Machado RF; Pimentel A; Dos Reis LM; de Pina LC; Redner P; Caldas PCS; Fandinho-Montes FCO; Borga L; Leite SP; da Rocha JL; Bastos LS; Ramos JP; Degrave WM; Antunes LCM; Galvão TC
Tuberculosis (Edinb); 2018 Dec; 113():163-174. PubMed ID: 30514498
[TBL] [Abstract][Full Text] [Related]
10. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
[TBL] [Abstract][Full Text] [Related]
11. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
[TBL] [Abstract][Full Text] [Related]
12. An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.
Ang ML; Zainul Rahim SZ; Shui G; Dianiškova P; Madacki J; Lin W; Koh VH; Martinez Gomez JM; Sudarkodi S; Bendt A; Wenk M; Mikušová K; Korduláková J; Pethe K; Alonso S
Infect Immun; 2014 May; 82(5):1850-9. PubMed ID: 24566628
[TBL] [Abstract][Full Text] [Related]
13. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.
Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P
Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218
[TBL] [Abstract][Full Text] [Related]
14. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
15. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the antituberculosis drug ethionamide.
Vale N; Gomes P; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):151-8. PubMed ID: 23215813
[TBL] [Abstract][Full Text] [Related]
17. Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands.
Carette X; Blondiaux N; Willery E; Hoos S; Lecat-Guillet N; Lens Z; Wohlkönig A; Wintjens R; Soror SH; Frénois F; Dirié B; Villeret V; England P; Lippens G; Deprez B; Locht C; Willand N; Baulard AR
Nucleic Acids Res; 2012 Apr; 40(7):3018-30. PubMed ID: 22156370
[TBL] [Abstract][Full Text] [Related]
18. Structural and docking studies of potent ethionamide boosters.
Tatum NJ; Villemagne B; Willand N; Deprez B; Liebeschuetz JW; Baulard AR; Pohl E
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1243-50. PubMed ID: 24192167
[TBL] [Abstract][Full Text] [Related]
19. EthA/R-Independent Killing of
Ang MLT; Zainul Rahim SZ; de Sessions PF; Lin W; Koh V; Pethe K; Hibberd ML; Alonso S
Front Microbiol; 2017; 8():710. PubMed ID: 28487681
[TBL] [Abstract][Full Text] [Related]
20. Mutation in Eth A protein of Mycobacterium tuberculosis conferred drug tolerance against enthinoamide in Mycobacterium smegmatis mc
Anand PK; Kumar A; Saini A; Kaur J
Comput Biol Chem; 2022 Jun; 98():107677. PubMed ID: 35397466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
